Hudson Bay Capital Management LP Beam Therapeutics Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 100,000 shares of BEAM stock, worth $2.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000
Previous 115,000
13.04%
Holding current value
$2.42 Million
Previous $2.82 Million
11.96%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$200 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$185 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$185 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$171 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$110 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.7B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...